Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - CASH FROM OPERATIONS
Cash from Operations ELVN - Enliven Therapeutics, Inc.
-61.3 M
LAST VALUE
-78.94%
2 YEAR CAGR
-47.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR